Alcobra Ltd. (ADHD) Reports Full Clinical Hold on IND Applications for MDX and Phase III MEASURE Study
Go back to Alcobra Ltd. (ADHD) Reports Full Clinical Hold on IND Applications for MDX and Phase III MEASURE Study| ALCOBRA (NASDAQ: ADHD) | Delayed: 1.46 +0.06 (4.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.40 | 52 Week High | $6.80 | |||
| Open | $1.40 | 52 Week Low | $1.77 | |||
| Day High | $1.64 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $0.00 | |||
| Volume | 1,107,893 | |||||
